<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-138232</identifier>
<setSpec>0300-2896</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">SEPAR-ALAT Consensus Document on Antipneumoccal Vaccination in Smokers</dc:title>
<dc:description xml:lang="en">Streptococcus pneumoniae is responsible for several clinical syndromes, such as community-acquired pneumonia, sinusitis, otitis media, and others. The most severe clinical entity caused by this bacteria is undoubtedly invasive pneumococcal disease. Certain factors are known to increase the risk of presenting invasive pneumococcal disease, the most important being smoking habit and underlying concomitant diseases. This article comprises a consensus document on antipneumococcal vaccination in smokers, drawn up by a Smoking Expert Group from the Spanish Society of Pulmonology and Thoracic Surgery and the Latin American Chest Association (AU)</dc:description>
<dc:creator>Zabert, Gustavo</dc:creator>
<dc:creator>Riesco Miranda, Juan Antonio</dc:creator>
<dc:creator>Casas Herrera, Alejandro</dc:creator>
<dc:creator>Solano Reina, Segismundo</dc:creator>
<dc:creator>Buljubasich, Daniel</dc:creator>
<dc:creator>Sansores, Raúl</dc:creator>
<dc:creator>Lucas Ramos, Pilar de</dc:creator>
<dc:creator>Chatkin, José Miguel</dc:creator>
<dc:creator>Guerreros Benavides, Alfredo</dc:creator>
<dc:creator>Granda Orive,  José Ignacio de</dc:creator>
<dc:creator>Jiménez Ruiz, Carlos A</dc:creator>
<dc:creator>Luhning,  Susana</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Streptococcus pneumoniae es causante de diversos cuadros clínicos: neumonía adquirida en la comunidad, sinusitis, otitis media, etc. Sin duda, la forma clínica más grave ocasionada por este germen es la enfermedad neumocócica invasiva. Se sabe que determinados factores, entre los que destaca el consumo de tabaco, y el padecimiento de enfermedades subyacentes concomitantes aumentan el riesgo de padecer estos procesos. Este artículo muestra un documento de consenso sobre vacunación antineumocócica en fumadores que ha sido realizado por un grupo de expertos en tabaquismo de la Sociedad Española de Neumología y Cirugía Torácica y de la Asociación Latinoamericana del Tórax (AU)</dc:description>
<dc:source>Arch Bronconeumol;51(7): 350-354, jul. 2015. tab</dc:source>
<dc:identifier>ibc-138232</dc:identifier>
<dc:title xml:lang="es">Documento de consenso SEPAR-ALAT sobre vacunación antineumocócica en fumadores</dc:title>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d19278^s22054</dc:subject>
<dc:subject>^d35368^s22000</dc:subject>
<dc:subject>^d29627</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d11437^s22054</dc:subject>
<dc:subject>^d33939</dc:subject>
<dc:subject>^d23925^s22038</dc:subject>
<dc:type>article</dc:type>
<dc:date>201507</dc:date>
</metadata>
</record>
</ibecs-document>
